New vaccine strategy may better protect HIV patients from pneumonia

This study tested a new two-step vaccine approach to protect HIV-infected adults from pneumococcal infections, a common cause of serious illness in this group. The standard vaccine often doesn't work well in people with lower immune cell counts. The study involved 212 participants and compared the new prime-boost strategy to the standard single vaccine, measuring immune response and safety.